Funding of Phase II SBIR Contract. N44 DA-12-2227

根据本小型企业创新研究（SBIR）第二阶段项目，“自动化直接观察治疗作为平台技术”，根据研究主题139，承包商应提供并评估用于监测治疗环境中药物依从性的系统的有效性和准确性。除监测外，该系统的一个内在组成部分将是一个综合通信平台，允许用户进行干预和反馈，并衡量系统的准确性。在对该系统进行进一步开发工作之后， 承包商将在临床试验中实施AiView-HR？系统，目的是（1）提供系统准确性的测量方法，以及（2）证明该系统可改善药物依从性。

Under this Small Business Innovation Research (SBIR) Phase II project, "Automating Directly Observed Therapy as a Platform Technology," under Research Topic 139, the Contractor shall provide and evaluate the effectiveness and accuracy of a system for monitoring medication adherence in a treatment setting. In addition to monitoring, an intrinsic component of the system will be an integrated communication platform allowing for intervention and feedback with the user and a measure of the accuracy of the system. Following additional development work on the system, the Contractor will implement the AiView-HR ¿ system in a clinical trial with the objectives of (1) providing a measure of the accuracy of the system, and (2) demonstrating that the system improves medication adherence.